Universal erythroderma, KELA reimbursement

L12_ERYTHRO_KELA

No definition available.

Endpoint definition

↥
FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

KELA reimbursements: KELA codes 134

1 out of 7 registries used, show all original rules.

402

diagram downward connector

Check minimum number of events None

402

diagram downward connector

Include endpoints None

402

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

389

diagram downward connector
L12_ERYTHRO_KELA

Control definitions

Control exclude L12_URTICARIAERYTHEMA

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 389 133 256
Unadjusted prevalence (%) 0.10 0.06 0.15
Mean age at first event (years) 48.76 46.09 50.14

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.04 2.64 [1.26, 5.52] 9.8e-3 65
15 years 0.01 1.28 [0.56, 2.96] 5.6e-1 29
5 years 0.00 1.97 [0.95, 4.08] 6.8e-2 13
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: L12_ERYTHRO_KELA – Universal erythroderma, KELA reimbursement
GWS hits: 2

Survival analyses between endpoints

↥

Plot

before Universal erythroderma, KELA reimbursement
after Universal erythroderma, KELA reimbursement

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Universal erythroderma, KELA reimbursement

↥

Endpoint not on priority list, no data to show.